Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma.
Sarfaty M, Leshno M, Gordon N, Moore A, Neiman V, Rosenbaum E, Goldstein DA. Sarfaty M, et al. Among authors: goldstein da. Eur Urol. 2018 Apr;73(4):628-634. doi: 10.1016/j.eururo.2017.07.041. Epub 2017 Aug 12. Eur Urol. 2018. PMID: 28807351
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data.
Dudnik E, Moskovitz M, Daher S, Shamai S, Hanovich E, Grubstein A, Shochat T, Wollner M, Bar J, Merimsky O, Zer A, Goldstein DA, Hammerman A, Cyjon A, Shechtman Y, Abu-Amna M, Flex D, Roisman LC, Peled N; Israel Lung Cancer Group. Dudnik E, et al. Among authors: goldstein da. Lung Cancer. 2018 Dec;126:217-223. doi: 10.1016/j.lungcan.2017.11.015. Epub 2017 Nov 23. Lung Cancer. 2018. PMID: 29254746
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer.
Sarfaty M, Hall PS, Chan KKW, Virik K, Leshno M, Gordon N, Moore A, Neiman V, Rosenbaum E, Goldstein DA. Sarfaty M, et al. Among authors: goldstein da. Eur Urol. 2018 Jul;74(1):57-62. doi: 10.1016/j.eururo.2018.03.006. Epub 2018 Mar 22. Eur Urol. 2018. PMID: 29576265 Free article.
441 results